<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33226711</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9568</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The European journal of neuroscience</Title><ISOAbbreviation>Eur J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Mutation analysis of MFSD8 in an amyotrophic lateral sclerosis cohort from mainland China.</ArticleTitle><Pagination><StartPage>1197</StartPage><EndPage>1206</EndPage><MedlinePgn>1197-1206</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ejn.15058</ELocationID><Abstract><AbstractText>Recent studies have suggested that rare variants in MFSD8 contribute to risk for frontotemporal dementia (FTD). Considering the common underlying pathogenesis and the shared genetic risk between amyotrophic lateral sclerosis (ALS) and FTD, we screened the coding region of MFSD8 in 551 unrelated patients with ALS (510 unrelated sporadic ALS and 41 familial ALS probands) from mainland China by whole-exome sequencing to assess its mutation frequency in patients with ALS and evaluate its association. Two rare deleterious variants, c.343G&gt;A (p. V115M) and c.695T&gt;C (p.L232P), were identified in this study. The variant c.695T&gt;C (p.L232P) has not been previously reported and the carrier of this variant exhibits a relatively younger age of disease onset. Our studies provide some independent evidence showing that the rare variant p.L232P in MFSD8 might be a candidate risk factor for ALS. However, the relatively small sample size&#xa0;and the lack of patient-derived cells limit the power of the genetic exploration of this study, further robust multicenter studies with larger sizes and biological experiments with patient-derived cells are needed to elucidate the pathogenesis of the rare variant in MFSD8 in ALS.</AbstractText><CopyrightInformation>&#xa9; 2020 Federation of European Neuroscience Societies and John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yanchun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Medical Genetics, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Medical Genetics, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Beisha</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Medical Genetics, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Management Center, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Junling</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Medical Genetics, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Lifang</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1704-8436</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>RefSeq</DataBankName><AccessionNumberList><AccessionNumber>NM_152778</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Eur J Neurosci</MedlineTA><NlmUniqueID>8918110</NlmUniqueID><ISSNLinking>0953-816X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C522398">MFSD8 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026901" MajorTopicYN="N">Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">burden analysis</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">whole-exome sequencing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>23</Day><Hour>12</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33226711</ArticleId><ArticleId IdType="doi">10.1111/ejn.15058</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., &amp; Sunyaev, S. R. (2010). A method and server for predicting damaging missense mutations. Nature Methods, 7, 248-249. https://doi.org/10.1038/nmeth0410-248</Citation></Reference><Reference><Citation>Audano, M., Schneider, A., &amp; Mitro, N. (2018). Mitochondria, lysosomes, and dysfunction: Their meaning in neurodegeneration. Journal of Neurochemistry, 147, 291-309. https://doi.org/10.1111/jnc.14471</Citation></Reference><Reference><Citation>Brown, R. H., &amp; Al-Chalabi, A. (2017). Amyotrophic lateral sclerosis. New England Journal of Medicine, 377, 162-172. https://doi.org/10.1056/NEJMra1603471</Citation></Reference><Reference><Citation>Caroppo, P., Camuzat, A., Guillot-Noel, L., Thomas-Anterion, C., Couratier, P., Wong, T. H., Teichmann, M., Golfier, V., Auriacombe, S., Belliard, S., Laurent, B., Lattante, S., Millecamps, S., Clot, F., Dubois, B., van Swieten, J. C., Brice, A., &amp; Le Ber, I. (2016). Defining the spectrum of frontotemporal dementias associated with TARDBP mutations. Neurology Genetics, 2, e80. https://doi.org/10.1212/NXG.0000000000000080</Citation></Reference><Reference><Citation>Chun, S., &amp; Fay, J. C. (2009). Identification of deleterious mutations within three human genomes. Genome Research, 19, 1553-1561. https://doi.org/10.1101/gr.092619.109</Citation></Reference><Reference><Citation>Dong, C., Wei, P., Jian, X., Gibbs, R., Boerwinkle, E., Wang, K., &amp; Liu, X. (2015). Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Human Molecular Genetics, 24, 2125-2137. https://doi.org/10.1093/hmg/ddu733</Citation></Reference><Reference><Citation>Ferrari, R., Kapogiannis, D., Huey, E. D., &amp; Momeni, P. (2011). FTD and ALS: A tale of two diseases. Current Alzheimer Research, 8, 273-294.</Citation></Reference><Reference><Citation>Geier, E. G., Bourdenx, M., Storm, N. J., Cochran, J. N., Sirkis, D. W., Hwang, J. H., Bonham, L. W., Ramos, E. M., Diaz, A., Van Berlo, V., Dokuru, D., Nana, A. L., Karydas, A., Balestra, M. E., Huang, Y., Russo, S. P., Spina, S., Grinberg, L. T., Seeley, W. W., &#x2026; Yokoyama, J. S. (2019). Rare variants in the neuronal ceroid lipofuscinosis geneMFSD8 are candidate risk factors for frontotemporal dementia. Acta Neuropathologica, 137, 71-88. https://doi.org/10.1007/s00401-018-1925-9</Citation></Reference><Reference><Citation>Jagadeesh, K. A., Wenger, A. M., Berger, M. J., Guturu, H., Stenson, P. D., Cooper, D. N., Bernstein, J. A., &amp; Bejerano, G. (2016). M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nature Genetics, 48, 1581-1586. https://doi.org/10.1038/ng.3703</Citation></Reference><Reference><Citation>Jiao, B., Tang, B., Liu, X., Yan, X., Zhou, L., Yang, Y., Wang, J., Xia, K., &amp; Shen, L. (2014). Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China. Neurobiology of Aging, 35(936), e919-922. https://doi.org/10.1016/j.neurobiolaging.2013.10.001</Citation></Reference><Reference><Citation>Karch, C. M., Wen, N., Fan, C. C., Yokoyama, J. S., Kouri, N., Ross, O. A., Hoglinger, G., Muller, U., Ferrari, R., Hardy, J., Schellenberg, G. D., Sleiman, P. M., Momeni, P., Hess, C. P., Miller, B. L., Sharma, M., Van Deerlin, V., Smeland, O. B., Andreassen, O. A., &#x2026; Desikan, R. S. (2018). Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum. JAMA Neurology, 75, 860-875. https://doi.org/10.1001/jamaneurol.2018.0372</Citation></Reference><Reference><Citation>Kircher, M., Witten, D. M., Jain, P., O'Roak, B. J., Cooper, G. M., &amp; Shendure, J. (2014). A general framework for estimating the relative pathogenicity of human genetic variants. Nature Genetics, 46, 310-315. https://doi.org/10.1038/ng.2892</Citation></Reference><Reference><Citation>Kousi, M., Siintola, E., Dvorakova, L., Vlaskova, H., Turnbull, J., Topcu, M., Yuksel, D., Gokben, S., Minassian, B. A., Elleder, M., Mole, S. E., &amp; Lehesjoki, A. E. (2009). Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis. Brain, 132, 810-819. https://doi.org/10.1093/brain/awn366</Citation></Reference><Reference><Citation>Kumar, P., Henikoff, S., &amp; Ng, P. C. (2009). Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature Protocols, 4, 1073-1081. https://doi.org/10.1038/nprot.2009.86</Citation></Reference><Reference><Citation>Ludolph, A., Drory, V., Hardiman, O., Nakano, I., Ravits, J., Robberecht, W., &amp; Shefner, J. (2015). A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener, 16, 291-292. https://doi.org/10.3109/21678421.2015.1049183</Citation></Reference><Reference><Citation>Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chio, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., van Swieten, J. C., Abramzon, Y., Johnson, J. O., Sendtner, M., Pamphlett, R., Orrell, R. W., Mead, S., Sidle, K. C., Houlden, H., &#x2026; Traynor, B. J. (2012). Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study. The Lancet Neurology, 11, 323-330. https://doi.org/10.1016/S1474-4422(12)70043-1</Citation></Reference><Reference><Citation>Mathis, S., Goizet, C., Soulages, A., Vallat, J. M., &amp; Masson, G. L. (2019). Genetics of amyotrophic lateral sclerosis: A review. Journal of the Neurological Sciences, 399, 217-226. https://doi.org/10.1016/j.jns.2019.02.030</Citation></Reference><Reference><Citation>Pires, D. E., Ascher, D. B., &amp; Blundell, T. L. (2014). mCSM: Predicting the effects of mutations in proteins using graph-based signatures. Bioinformatics, 30, 335-342. https://doi.org/10.1093/bioinformatics/btt691</Citation></Reference><Reference><Citation>Quadri, M., Mandemakers, W., Grochowska, M. M., Masius, R., Geut, H., Fabrizio, E., Breedveld, G. J., Kuipers, D., Minneboo, M., Vergouw, L. J. M., Carreras Mascaro, A., Yonova-Doing, E., Simons, E., Zhao, T., Di Fonzo, A. B., Chang, H.-C., Parchi, P., Melis, M., Correia Guedes, L., &#x2026; Melis, M. (2018). LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: A genome-wide linkage and sequencing study. The Lancet Neurology, 17, 597-608. https://doi.org/10.1016/S1474-4422(18)30179-0</Citation></Reference><Reference><Citation>Renton, A. E., Chi&#xf2;, A., &amp; Traynor, B. J. (2014). State of play in amyotrophic lateral sclerosis genetics. Nature Neuroscience, 17, 17-23. https://doi.org/10.1038/nn.3584</Citation></Reference><Reference><Citation>Reva, B., Antipin, Y., &amp; Sander, C. (2011). Predicting the functional impact of protein mutations: Application to cancer genomics. Nucleic Acids Research, 39, e118. https://doi.org/10.1093/nar/gkr407</Citation></Reference><Reference><Citation>Ringholz, G. M., Appel, S. H., Bradshaw, M., Cooke, N. A., Mosnik, D. M., &amp; Schulz, P. E. (2005). Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology, 65, 586-590. https://doi.org/10.1212/01.wnl.0000172911.39167.b6</Citation></Reference><Reference><Citation>Schwarz, J. M., R&#xf6;delsperger, C., Schuelke, M., &amp; Seelow, D. (2010). MutationTaster evaluates disease-causing potential of sequence alterations. Nature Methods, 7, 575-576. https://doi.org/10.1038/nmeth0810-575</Citation></Reference><Reference><Citation>Shihab, H. A., Gough, J., Cooper, D. N., Day, I. N., &amp; Gaunt, T. R. (2013). Predicting the functional consequences of cancer-associated amino acid substitutions. Bioinformatics, 29, 1504-1510. https://doi.org/10.1093/bioinformatics/btt182</Citation></Reference><Reference><Citation>Siintola, E., Topcu, M., Aula, N., Lohi, H., Minassian, B. A., Paterson, A. D., Liu, X. Q., Wilson, C., Lahtinen, U., Anttonen, A. K., &amp; Lehesjoki, A. E. (2007). The novel neuronal ceroid lipofuscinosis geneMFSD8 encodes a putative lysosomal transporter. American Journal of Human Genetics, 81, 136-146. https://doi.org/10.1086/518902</Citation></Reference><Reference><Citation>Steenhuis, P., Herder, S., Gelis, S., Braulke, T., &amp; Storch, S. (2010). Lysosomal targeting of the CLN7 membrane glycoprotein and transport via the plasma membrane require a dileucine motif. Traffic, 11, 987-1000. https://doi.org/10.1111/j.1600-0854.2010.01073.x</Citation></Reference><Reference><Citation>Stogmann, E., El Tawil, S., Wagenstaller, J., Gaber, A., Edris, S., Abdelhady, A., Assem-Hilger, E., Leutmezer, F., Bonelli, S., Baumgartner, C., Zimprich, F., Strom, T. M., &amp; Zimprich, A. (2009). A novel mutation in theMFSD8 gene in late infantile neuronal ceroid lipofuscinosis. Neurogenetics, 10, 73-77. https://doi.org/10.1007/s10048-008-0153-1</Citation></Reference><Reference><Citation>van Blitterswijk, M., van Es, M. A., Hennekam, E. A., Dooijes, D., van Rheenen, W., Medic, J., Bourque, P. R., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., de Bakker, P. I., Veldink, J. H., &amp; van den Berg, L. H. (2012). Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Human Molecular Genetics, 21, 3776-3784. https://doi.org/10.1093/hmg/dds199</Citation></Reference><Reference><Citation>Wang, J. L., Cao, L., Li, X. H., Hu, Z. M., Li, J. D., Zhang, J. G., Liang, Y., San, A., Li, N., Chen, S. Q., Guo, J. F., Jiang, H., Shen, L., Zheng, L., Mao, X., Yan, W. Q., Zhou, Y., Shi, Y. T., Ai, S. X., &#x2026; Tang, B. S. (2011). Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain, 134, 3493-3501. https://doi.org/10.1093/brain/awr289</Citation></Reference><Reference><Citation>Worth, C. L., Preissner, R., &amp; Blundell, T. L. (2011). SDM - A server for predicting effects of mutations on protein stability and malfunction. Nucleic Acids Research, 39, W215-W222. https://doi.org/10.1093/nar/gkr363</Citation></Reference><Reference><Citation>Zhang, M., Xi, Z., Zinman, L., Bruni, A. C., Maletta, R. G., Curcio, S. A., Rainero, I., Rubino, E., Pinessi, L., Nacmias, B., Sorbi, S., Galimberti, D., Lang, A. E., Fox, S., Surace, E. I., Ghani, M., Guo, J., Sato, C., Moreno, D., &#x2026; Rogaeva, E. (2015). Mutation analysis of CHCHD10 in different neurodegenerative diseases. Brain, 138, e380. https://doi.org/10.1093/brain/awv082</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>